loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering 8900566

    Client Virtual Booth
    Menu

    Bristol Myers Squibb

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BRISTOL-MYERS SQUIBB (4)

    filter

    01 8900566 (4)

    filter

    01 Blank (4)

    filter

    01 Blank (4)

    filter

    01 2027-08-08 (4)

    refreshReset Filter
    refreshReset Filter
    price-trendAsk Us

    BRISTOL-MYERS SQUIBB

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DACLATASVIR DIHYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8900566
    2027-08-08
    U-1725
    206843
    METHOD OF INHIBITING HEPATITIS C VIRUS WITH DAKLINZA AND AT LEAST ONE ADDITIONAL COMPOUND HAVING ANTI-HCV ACTIVITY
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    BRISTOL-MYERS SQUIBB

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DACLATASVIR DIHYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8900566
    2027-08-08
    U-1724
    206843
    METHOD OF INHIBITING HEPATITIS C VIRUS
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    BRISTOL-MYERS SQUIBB

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DACLATASVIR DIHYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8900566
    2027-08-08
    U-1724
    206843
    METHOD OF INHIBITING HEPATITIS C VIRUS
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    BRISTOL-MYERS SQUIBB

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DACLATASVIR DIHYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    8900566
    2027-08-08
    U-1725
    206843
    METHOD OF INHIBITING HEPATITIS C VIRUS WITH DAKLINZA AND AT LEAST ONE ADDITIONAL COMPOUND HAVING ANTI-HCV ACTIVITY
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY